Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Avadel Pharmaceuticals plc - Ordinary Share (NQ:AVDL)

21.40 -0.10 (-0.47%)

Streaming Delayed Price Updated: 3:02 PM EST, Jan 8, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,936,864
Open	21.47
Bid (Size)	21.40 (2,700)
Ask (Size)	21.41 (1,400)
Prev. Close	21.50
Today's Range	21.39 - 21.50
52wk Range	6.380 - 23.57
Shares Outstanding	96,116,323
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Halper Sadeh LLC Encourages AVDL, CMA, KVUE Shareholders to Contact the Firm to Discuss Their Rights

December 14, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

Avadel Pharmaceuticals (NASDAQ:AVDL) Combines Strong Growth Momentum with Favorable Technical Setup ↗

December 13, 2025

Avadel Pharmaceuticals (AVDL) combines strong revenue growth, a shift to profitability, and a solid technical uptrend, offering a potential entry for momentum investors.

Via Chartmill

Performance

YTD	-0.6%	-0.6%
1 Month	+0.4%	+0.4%
3 Month	+50.6%	+50.6%
6 Month	+124.1%	+124.1%
1 Year	+97.1%	+97.1%

More News

Halper Sadeh LLC Encourages GIFI, AVDL, JAMF, CDE Shareholders to Contact the Firm to Discuss Their Rights

December 04, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Race For Avadel Heats Up: Alkermes Raises Offer To Secure $2.37B Deal After Lundbeck Challenge ↗

November 19, 2025

Via Stocktwits

Halper Sadeh LLC Encourages HFWA, FITB, AVDL, BRNS Shareholders to Contact the Firm to Discuss Their Rights

November 18, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Top 2 Health Care Stocks That May Fall Off A Cliff This Month ↗

November 17, 2025

Via Benzinga

Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal ↗

November 14, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

November 14, 2025

Via Chartmill

Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday ↗

November 14, 2025

Via Benzinga

Avadel Surges 20% On Lundbeck's Surprise Alkermes-Topping Bid ↗

November 14, 2025

Via Investor's Business Daily

Halper Sadeh LLC Encourages TRUE, AVDL, GES Shareholders to Contact the Firm to Discuss Their Rights

November 14, 2025

From Halper Sadeh LLC

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 14, 2025

Via Benzinga

Avadel Gets Acquisition Proposal From Lundbeck Weeks After Inking Agreement With Alkermes ↗

November 14, 2025

Via Stocktwits

Avadel Pharmaceuticals (NASDAQ:AVDL) Meets Minervini Trend Template with High-Growth Momentum ↗

November 06, 2025

Via Chartmill

Deal Dispatch: From Four Roses Bourbon To Quantum Stakes, Here Are This Week's Sector Shake Ups ↗

October 24, 2025

Via Benzinga

HALPER SADEH LLC ENCOURAGES FSFG, AVDL, MBCN SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

October 23, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Tesla To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Thursday ↗

October 23, 2025

Via Benzinga

This Winnebago Industries Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗

October 23, 2025

Via Benzinga

Avadel Pharmaceuticals Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avadel Pharmaceuticals plc - AVDL

October 22, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz ↗

October 22, 2025

Via Benzinga

Beyond The Numbers: 5 Analysts Discuss Avadel Pharmaceuticals Stock ↗

October 22, 2025

Via Benzinga

Avadel Pharmaceuticals Soars as Alkermes Announces $2.1 Billion Acquisition

October 22, 2025

Via MarketMinute

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avadel Pharmaceuticals plc (Nasdaq – AVDL), Middlefield Banc Corp. (Nasdaq – MBCN), Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated

October 22, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Avadel Jumps On $2.1 Billion Takeover Deal. But Buyer, Alkermes, Dives. ↗

October 22, 2025

Via Investor's Business Daily

Avadel Stock Rises After Acquisition Offer By Alkermes ↗

October 22, 2025

Via Stocktwits

Frequently Asked Questions

Is Avadel Pharmaceuticals plc - Ordinary Share publicly traded?

Yes, Avadel Pharmaceuticals plc - Ordinary Share is publicly traded.

What exchange does Avadel Pharmaceuticals plc - Ordinary Share trade on?

Avadel Pharmaceuticals plc - Ordinary Share trades on the Nasdaq Stock Market

What is the ticker symbol for Avadel Pharmaceuticals plc - Ordinary Share?

The ticker symbol for Avadel Pharmaceuticals plc - Ordinary Share is AVDL on the Nasdaq Stock Market

What is the current price of Avadel Pharmaceuticals plc - Ordinary Share?

The current price of Avadel Pharmaceuticals plc - Ordinary Share is 21.40

When was Avadel Pharmaceuticals plc - Ordinary Share last traded?

The last trade of Avadel Pharmaceuticals plc - Ordinary Share was at 01/08/26 03:02 PM ET

What is the market capitalization of Avadel Pharmaceuticals plc - Ordinary Share?

The market capitalization of Avadel Pharmaceuticals plc - Ordinary Share is 2.06B

How many shares of Avadel Pharmaceuticals plc - Ordinary Share are outstanding?

Avadel Pharmaceuticals plc - Ordinary Share has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.